CS logo
small CS logo
Galenos Research

Dallas, Texas, United States
Research institute in Dallas, Texas
12201 Merit Dr Suite 180, Dallas, TX 75251

About Galenos Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Gilead Sciences
2
Mannkind Corporation
2
Pfizer
2
Purdue Pharma LP
2
Anji Pharma
1
Elcelyx Therapeutics, Inc.
1
Logical Therapeutics
1
Robert Lodder
1
Sucampo Pharma Americas, LLC
1
Total Rows: 10

Clinical Trials at Galenos Research


During the past decade, Galenos Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33000000001111110000113311110000Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
2006-02-01
2008-09-01
Completed
677
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain
2004-02-01
2005-09-01
Terminated
660
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
A 2-Month Safety Follow-Up Trial
2007-05-01
2008-09-01
Completed
649
Naturlose (D-Tagatose) Efficacy Evaluation Trial
2007-04-01
2010-10-01
Completed
494
Rates of Gastric Ulcer by Endoscopy in Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn®
2010-02-01
2010-11-01
Completed
534
Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015
2004-06-01
2008-01-01
Terminated
354

Rows per page:

1–17 of 17

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Galenos Research" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Mannkind Corporation" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Purdue Pharma LP" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Galenos Research" #1 collaborator was "PRA Health Sciences" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "University of Kentucky" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 4Eli Lilly and Company: 4Gilead Sciences: 2Gilead Sciences: 2Mannkind Corporation: 2Mannkind Corporation: 2Pfizer: 2Pfizer: 2Purdue Pharma LP: 2Purdue Pharma LP: 2Anji Pharma: 1Anji Pharma: 1Elcelyx Therapeutics, Inc.: 1Elcelyx Therapeutics, Inc.: 1Logical Therapeutics: 1Logical Therapeutics: 1Robert Lodder: 1Robert Lodder: 1Sucampo PharmaAmericas, LLC: 1Sucampo PharmaAmericas, LLC: 1

Created with Highcharts 11.1.0Top CollaboratorsPRA Health Sciences: 1PRA Health Sciences: 1SucampoPharmaceuticals, Inc.: 1SucampoPharmaceuticals, Inc.: 1University of Kentucky: 1University of Kentucky: 1

Clinical Trials Conditions at Galenos Research


According to Clinical.Site data, the most researched conditions in "Galenos Research" are "Type 2 Diabetes Mellitus" (3 trials), "Back Pain Lower Back Chronic" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Hypertension" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Galenos Research" in a lesser frequency.

Clinical Trials Intervention Types at Galenos Research


Most popular intervention types in "Galenos Research" are "Drug" (17 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Darusentan" (2 trials), "Dulaglutide" (2 trials), "Guanfacine" (2 trials) and "Metformin" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Galenos Research


The vast majority of trials in "Galenos Research" are 17 trials for "All" genders.

Clinical Trials Status at Galenos Research


Currently, there are NaN active trials in "Galenos Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Galenos Research, 1 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Galenos Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 14Phase 3: 14Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Terminated: 4Terminated: 4Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Suspended: 1Suspended: 1